Black Rock Inc. Synlogic, Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.42 - $0.68 $63,741 - $103,200	-151,765 Reduced 33.59%	300,109 $129,000
Q1 2023 May 12, 2023	BUY	$0.56 - $1.07 $8,373 - $15,998	14,952 Added 3.42%	451,874 $284,000
Q4 2022 Feb 13, 2023	BUY	$0.58 - $17.99 $3,703 - $114,866	6,385 Added 1.48%	436,922 $332,000
Q3 2022 Nov 14, 2022	SELL	$0.91 - $14.63 $2,871 - $46,157	-3,155 Reduced 0.73%	430,537 $410,000
Q2 2022 Aug 12, 2022	BUY	$0.89 - $2.47 $22,733 - $63,091	25,543 Added 6.26%	433,692 $499,000
Q1 2022 May 12, 2022	BUY	$1.63 - $2.55 $11,442 - $17,901	7,020 Added 1.75%	408,149 $980,000
Q4 2021 Feb 10, 2022	BUY	$2.27 - $3.0 $63,945 - $84,510	28,170 Added 7.55%	401,129 $971,000
Q3 2021 Nov 09, 2021	BUY	$2.45 - $4.1 $14,692 - $24,587	5,997 Added 1.63%	372,959 $1.14 Million
Q2 2021 Aug 11, 2021	BUY	$3.0 - $4.39 $1.1 Million - $1.61 Million	366,962 New	366,962 $1.43 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.